Made in Ireland: ABEC adds cleanroom to make large-scale disposable tech

By Flora Southey

- Last updated on GMT

GettyImages/Delpixart
GettyImages/Delpixart

Related tags Disposable

ABEC has expanded manufacturing in Ireland with the completion of an ISO-7 cleanroom, where the single-use vendor will make disposable bioreactor bags for global distribution.

The 3,335 sq. ft. cleanroom is located in Fermoy, Ireland, and will more than double manufacturing capacity for its single-use bioreactor bags – known at ABEC as disposable containers (DCs) – said the firm.

The class ISO-7 site houses a dedicated manufacturing area, CNC (controlled not classified) and airlock space, and is expected to be open this April.

The expansion responds to increased demand globally, in Asia, Europe and North America, said spokesperson Susan Cooper-Curcio.

“ABEC’s Custom Single Run (CSR) 4,000L bioreactor and the 5,000L general mixing are the most sought after, which is driven by customers’ interest in achieving economies of scale and greater process flexibility in single-use manufacturing,” ​we were told.

The Fermoy site – design and constructed by contractors Clearsphere and Kingspan – marks ABEC’s second cleanroom capacity after its Bethlehem, Pennsylvania site in the US.

In Ireland, ABEC also has manufacturing sites in Kells, County Meath and an existing facility in Fermoy.

The firm said it expects growing demand in the CSR product line to result in added jobs.

Supply chain security

ABEC said the Fermoy site will help meet customers’ quality and scheduling needs.

“A flexible and reliable supply of high quality DCs is critical to our customers’ single-use manufacturing operations.

“ABEC’s new state-of-the art cleanroom in Fermoy greatly enhances our DC supply capability and further reduces our customers’ single-use supply chain risk,” ​said CEO Scott Pickering.

In 2015, ABEC launched​ a 4,300L single-use bioreactor – the largest on the market at that time – with a working volume of 3,500L.

In July last year, the firm increased​ that offering to 4,900L.

Related news

Show more

Related products

Trends in Biopharmaceutical Raw Material Selection

Trends in Biopharmaceutical Raw Material Selection

Actylis – The Partner of Choice | 31-Jan-2023 | Business Advice

Join us as our in-house experts, along with Cecile Bellamy from Pfizer, discuss current and future trends in biopharmaceutical raw material selection.

Liposomal and Nanoparticle Technology

Liposomal and Nanoparticle Technology

Pfizer CentreOne | 18-Nov-2022 | Technical / White Paper

Medical science is continuously searching for better ways to administer drugs into the body and to maximize the therapeutic effectiveness of the drugs...

Discover the world of upstream bioprocessing

Discover the world of upstream bioprocessing

Eppendorf Bioprocess Solutions | 07-Sep-2022 | Technical / White Paper

A must-read for all bioprocess scientists: This bundle of four ebooks created by Eppendorf guides you through the world of upstream bioprocessing.

The Reagents Behind Much of Molecular Biology

The Reagents Behind Much of Molecular Biology

Thermo Fisher Scientific | 25-Jul-2022 | Case Study

The ability to amplify, modify and fabricate DNA is fundamental to modern molecular biology. Why do so many researchers take their constituent parts for...

Related suppliers

Follow us

Products

View more

Webinars